Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Recall
Recall Date
Apr 15, 2026
Company
Teva Pharmaceuticals USA, Inc
Source
FDA
Units
62,136 Cartons
Reason: CGMP Deviations: use of an unapproved raw material
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Description
CGMP Deviations: use of an unapproved raw material
Reason for Recall
CGMP Deviations: use of an unapproved raw material
What Should I Do?
Quantity: 62,136 Cartons
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
+2 more steps…
Last updated April 20, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.